Jazz Pharmaceuticals plc — Director's Dealing 2014

Aug 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-08-11

Reporting Person: Tobias Jeffrey K (EVP, Research & Dev and CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-08-11	Ordinary Shares	F	4565	$133.86	Disposed	42538	Direct
2014-08-11	Ordinary Shares	M	2561	$46.83	Acquired	45099	Direct
2014-08-11	Ordinary Shares	M	2372	$59.13	Acquired	47471	Direct
2014-08-11	Ordinary Shares	S	4933	$135.42	Disposed	42538	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-08-11	Nonstatutory Stock Option (right to buy)	$46.83	M	2561	Disposed	2022-08-08	Ordinary Shares (2561)	Direct
2014-08-11	Nonstatutory Stock Option (right to buy)	$59.13	M	2372	Disposed	2023-03-04	Ordinary Shares (2372)	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.12 to $135.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F4: Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 20,487 shares in equal monthly installments from September 9, 2014 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.

F5: Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 2,603 shares and will vest with respect to 2,084 shares in equal monthly installments from September 5, 2014 to December 5, 2014 and with respect to 12,500 shares in equal monthly installments from January 5, 2015 to December 5, 2016.